Airway and systemic effects of inhaled corticosteroids in asthma: 136 dose response relationship, Pulm Pharmacol, vol.9, pp.19-27, 1996. ,
Ritonavir-fluticasone interaction 138 causing Cushing syndrome in HIV-infected children and adolescents, Pediatr. Infect. Dis, 2006. ,
, J, vol.25, pp.1044-1048
Cushing's syndrome without excess 142 cortisol, BMJ, vol.332, pp.469-470, 2006. ,
Acute adrenal insufficiency associated with high dose inhaled 145 steroids, BMJ, vol.304, p.1415, 1992. ,
,
Interaction between 149 voriconazole and budesonide with clinical relevance (Cushing's syndrom), 2011. ,
, Abstracts. Basic & Clinical Pharmacology & Toxicology, vol.109, pp.41-71
Effect of 153 posaconazole on cytochrome P450 enzymes: a randomized, open-label, two-way 154 crossover study, Eur J Pharm Sci, vol.21, pp.645-653, 2004. ,
Iatrogenic Cushing syndrome due to nasal 157 steroid drops, Eur. J. Pediatr, vol.171, pp.735-736, 2012. ,
Rapid onset of 160 iatrogenic adrenal insufficiency in a patient with cystic fibrosis-related liver disease 161 treated with inhaled corticosteroids and a moderate CYP3A4 inhibitor, Ann, vol.162, p.38, 2011. ,
, , p.165
Drug interactions between inhaled corticosteroids and enzymatic 166 inhibitors, Eur. J. Clin. Pharmacol, vol.65, p.169, 2008. ,
, Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a 170 review of the literature, HIV Med, vol.9, pp.389-396
, , 2010.
, Efficacy and safety of posaconazole for chronic pulmonary aspergillosis, Clinical 174 infectious diseases, vol.51, pp.1383-1391
, , p.177
, , p.178
Comparison of epidemiological, p.179, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00699980
, biological features of invasive aspergillosis in neutropenic and 180 nonneutropenic patients: a 6-year survey, Clin. Infect. Dis, vol.43, pp.577-584